Advisory: Alert on GeneDx's Q2 revenue was erroneous and has been withdrawn
24/07/2025 24:50
The alert on GeneDx Holdings Corp's WGS.O second-quarter revenue is wrong and has been withdrawn. It was published inadvertently from a press release issued by shareholder rights law firm Bragar Eagel & Squire, P.C, which is unrelated. There will be no substitute for the alert. STORY_NUMBER:PLXC3F7F7 STORY_DATE:23/07/2025 STORY_TIME:[11:30:02] (Bangalore.newsroom@thomsonreuters.com)
Recent news on GeneDx Holdings
See all newsBrief: Genedx Launches New Online Offering For Families To Improve Accessibility Of Exome Testing For Children
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth